In vitro antitumor activity of cerivastatin, a novel and potent HMG-CoA reductase inhibitor

FEBS Lett. 2001 Aug 17;503(2-3):219-20. doi: 10.1016/s0014-5793(01)02736-3.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cell Division / drug effects
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
  • Lovastatin / pharmacology
  • Neovascularization, Pathologic / drug therapy
  • Pyridines / pharmacology*
  • Simvastatin / pharmacology
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyridines
  • Lovastatin
  • Simvastatin
  • cerivastatin